Acuta Capital Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-80,000
Closed -$2.39M 85
2017
Q2
$2.39M Buy
+80,000
New +$1.97M 0.67% 28

Other funds holding JUNO